A Cross-sectional Study on Intradialytic Hypertension at Four Haemodialysis Units in the Western Cape
1 other identifier
observational
200
1 country
1
Brief Summary
Observational evidence indicates that intradialytic hypertension is associated with high morbidity \& mortality. The investigators impression is that this problem may be more prevalent than initially suspected. To the investigators knowledge, there are no studies on intradialytic hypertension in the South African haemodialysis population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2013
CompletedStudy Start
First participant enrolled
April 1, 2013
CompletedFirst Posted
Study publicly available on registry
August 5, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedMay 7, 2014
May 1, 2014
1 year
February 1, 2013
May 6, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of intradialytic hypertension at four haemodialysis units in the Western Cape
Up to 1 year
Secondary Outcomes (1)
Participants pre- and post hemodialysis bioimpedance measurements
Up to 1 year
Eligibility Criteria
Chronic haemodialysis patients
You may qualify if:
- Males and females age \> 18 years
- Ability to give informed consent
You may not qualify if:
- Inability to take blood pressure by routine methods in the upper limbs
- Inability to give informed consent
- Contraindications to bioimpedance monitoring (pre-existing implanted cardiac devices such as pacemakers, cardioverter defibrillators; amputees)
- Intercurrent acute illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tygerberg Academic Hospital
Cape Town, Western Cape, 7505, South Africa
Study Officials
- PRINCIPAL INVESTIGATOR
Mogamat-Yazied Dr Chothia, FCP(SA)
University of Stellenbosch
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Nephrologist
Study Record Dates
First Submitted
February 1, 2013
First Posted
August 5, 2013
Study Start
April 1, 2013
Primary Completion
April 1, 2014
Study Completion
May 1, 2014
Last Updated
May 7, 2014
Record last verified: 2014-05